Moreover, there are studies indicating a correlation between the blood level of CPA3-MCs in patients with COVID-19 and the level of neutrophils in the blood, which also confirms the presence of not only a local effect of MCs on the chemotaxis of neutrophils to the site of inflammation, but also a systemic effect on the level of neutrophils in peripheral blood [19]. Here, CPA3 is linked to COVID-19.